These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6733874)

  • 1. Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia.
    Young DZ; Lampert S; Graboys TB; Lown B
    Circulation; 1984 Aug; 70(2):184-91. PubMed ID: 6733874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs.
    Graboys TB; Lown B; Podrid PJ; DeSilva R
    Am J Cardiol; 1982 Sep; 50(3):437-43. PubMed ID: 6180622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of moricizine hydrochloride in reducing chronic high-frequency ventricular arrhythmia: results of a prospective, controlled trial.
    Singh SN; DiBianco R; Gottdiener JS; Ginsberg R; Fletcher RD
    Am J Cardiol; 1984 Mar; 53(6):745-50. PubMed ID: 6367416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of ventricular arrhythmias.
    Aronow WS
    Compr Ther; 1988 Aug; 14(8):25-30. PubMed ID: 3048863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of antiarrhythmic response to encainide.
    Duff HJ; Roden DM; Carey EL; Wang T; Primm RK; Woosley RL
    Am J Cardiol; 1985 Nov; 56(13):887-91. PubMed ID: 3933319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of exercise testing in evaluation of arrhythmias.
    Podrid PJ; Venditti FJ; Levine PA; Klein MD
    Am J Cardiol; 1988 Oct; 62(12):24H-33H. PubMed ID: 3052006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiarrhythmic drugs on variability of ventricular rate and exercise performance in chronic atrial fibrillation complicated with ventricular arrhythmias.
    Hsieh MH; Chen SA; Wen ZC; Tai CT; Chiang CE; Ding YA; Chang MS
    Int J Cardiol; 1998 Mar; 64(1):37-45. PubMed ID: 9579815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.
    Wilber DJ; Olshansky B; Moran JF; Scanlon PJ
    Circulation; 1990 Aug; 82(2):350-8. PubMed ID: 2372886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience.
    Bigger JT
    Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise-induced ischaemia.
    Berntsen RF; Gunnes P; Lie M; Rasmussen K
    Eur Heart J; 1993 Oct; 14(10):1297-303. PubMed ID: 8262074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmias in acute myocardial infarction. A comparative study on some tests for ventricular arrhythmias.
    Abjörn C; Karlsson E; Sonnhag C
    Acta Med Scand; 1977 Jan; 201(1-2):119-25. PubMed ID: 835361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease.
    Lampert S; Lown B; Graboys TB; Podrid PJ; Blatt CM
    Am J Cardiol; 1988 Apr; 61(10):791-7. PubMed ID: 3354443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of arrhythmias, predictors for arrhythmias, and safety of exercise stress testing in children.
    Ghosh RM; Gates GJ; Walsh CA; Schiller MS; Pass RH; Ceresnak SR
    Pediatr Cardiol; 2015 Mar; 36(3):584-90. PubMed ID: 25384613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant ventricular arrhythmias in the subacute and late phases of myocardial infarction. Clinical arrhythmological characteristics and prognostic value].
    Proclemer A; Facchin D; Fresco C; Bernardi G; Fontanelli A; Feruglio GA
    G Ital Cardiol; 1990 May; 20(5):400-11. PubMed ID: 2210161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival.
    Kelly P; Ruskin JN; Vlahakes GJ; Buckley MJ; Freeman CS; Garan H
    J Am Coll Cardiol; 1990 Feb; 15(2):267-73. PubMed ID: 2299065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic testing and follow-up of patients with aborted sudden death.
    Eldar M; Sauve MJ; Scheinman MM
    J Am Coll Cardiol; 1987 Aug; 10(2):291-8. PubMed ID: 3598002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
    Weintraub AR; Manolis AS; Estes NA
    Am J Cardiol; 1990 Oct; 66(12):947-53. PubMed ID: 2121017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.